# Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer

> **NCT05908838** · EARLY_PHASE1 · COMPLETED · sponsor: **ShuGuang Hospital** · enrollment: 146 (actual)

## Conditions studied

- Gastric Cancer (Diagnosis)

## Interventions

- **DRUG:** Modified Banxia Xiexin Decoction
- **DRUG:** combination chemotherapy with Placebo granules

## Key facts

- **NCT ID:** NCT05908838
- **Lead sponsor:** ShuGuang Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-02
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05908838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05908838, "Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05908838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*